Intervention to Improve Communication and Medication Adherence in Lupus

NARecruitingINTERVENTIONAL
Enrollment

480

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

July 31, 2027

Study Completion Date

December 31, 2028

Conditions
Systemic Lupus Erythematosus
Interventions
BEHAVIORAL

CO-LEAD

The investigators will provide clinicians with a program to teach them to use effective communication strategies with patients to review real-time pharmacy refill data and the DOSE-Nonadherence-SLE survey, and engage and formulate solutions to adherence barriers together. The study team will provide the clinician intervention training in-person or virtually and will include didactics, demonstration, and practice that include two one-hour sessions one month apart. After training, CO-LEAD clinicians will be encouraged to incorporate the intervention in regular clinic visits with all patients.

Trial Locations (1)

27710

RECRUITING

Duke University, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Institute on Minority Health and Health Disparities (NIMHD)

NIH

lead

Duke University

OTHER

NCT06458075 - Intervention to Improve Communication and Medication Adherence in Lupus | Biotech Hunter | Biotech Hunter